Surrogate markers in HIV disease.
The use of surrogate markers in HIV disease is an attractive method of assessing the efficacy of new treatments more quickly than by using clinical end-points. The characteristics of an ideal surrogate marker and the theoretical dangers of extrapolating properties from one class of drug to another a...
Autor principal: | Peto, T |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
1996
|
Ítems similars
-
The validity of surrogate markers in rheumatic disease.
per: Emery, P, et al.
Publicat: (1993) -
High HPgV replication is associated with improved surrogate markers of HIV progression.
per: Gibran Horemheb-Rubio, et al.
Publicat: (2017-01-01) -
Study on the functional role of immunoglobulin E as surrogate marker for HIV/AIDS infection
per: Sonaimuthu B, et al.
Publicat: (2012-09-01) -
Surrogates Markers of Insulin Resistance
per: Ekhlas Khalid Hameed, et al.
Publicat: (2022-05-01) -
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.
per: Timo Rath, et al.
Publicat: (2014-01-01)